@article{YurdadoganMalschKotsevaetal.2021,
  author    = {Yurdadogan, Tino and Malsch, Carolin and Kotseva, Kornelia and Wood, David and Leyh, Rainer and Ertl, Georg and Karmann, Wolfgang and M{\"u}ller-Scholden, Lara and Morbach, Caroline and Breuning, Margret and Wagner, Martin and Gelbrich, G{\"o}tz and Bots, Michiel L. and Heuschmann, Peter U. and St{\"o}rk, Stefan},
  title     = {Functional versus morphological assessment of vascular age in patients with coronary heart disease},
  series = {Scientific Reports},
  volume    = {11},
  journal   = {Scientific Reports},
  number    = {1},
  doi       = {10.1038/s41598-021-96998-x},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-265810},
  year      = {2021},
  abstract  = {Communicating cardiovascular risk based on individual vascular age (VA) is a well acknowledged concept in patient education and disease prevention. VA may be derived functionally, e.g. by measurement of pulse wave velocity (PWV), or morphologically, e.g. by assessment of carotid intima-media thickness (cIMT). The purpose of this study was to investigate whether both approaches produce similar results. Within the context of the German subset of the EUROASPIRE IV survey, 501 patients with coronary heart disease underwent (a) oscillometric PWV measurement at the aortic, carotid-femoral and brachial-ankle site (PWVao, PWVcf, PWVba) and derivation of the aortic augmentation index (AIao); (b) bilateral cIMT assessment by high-resolution ultrasound at three sites (common, bulb, internal). Respective VA was calculated using published equations. According to VA derived from PWV, most patients exhibited values below chronological age indicating a counterintuitive healthier-than-anticipated vascular status: for VA(PWVao) in 68\% of patients; for VA\(_{AIao}\) in 52\% of patients. By contrast, VA derived from cIMT delivered opposite results: e.g. according to VA\(_{total-cIMT}\) accelerated vascular aging in 75\% of patients. To strengthen the concept of VA, further efforts are needed to better standardise the current approaches to estimate VA and, thereby, to improve comparability and clinical utility.},
  language  = {en}
}
@article{WalterGrussNeidlingeretal.2020,
  author    = {Walter, Steffen and Gruss, Sascha and Neidlinger, Jana and Stross, Isabelle and Hann, Alexander and Wagner, Martin and Seufferlein, Thomas and Walter, Benjamin},
  title     = {Evaluation of an Objective Measurement Tool for Stress Level Reduction by Individually Chosen Music During Colonoscopy—Results From the Study "ColoRelaxTone"},
  series = {Frontiers in Medicine},
  volume    = {7},
  journal   = {Frontiers in Medicine},
  doi       = {10.3389/fmed.2020.00525},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-212337},
  year      = {2020},
  abstract  = {Background and Aims: Colonoscopy as standard procedure in endoscopy is often perceived as uncomfortable for patients. Patient's anxiety is therefore a significant issue, which often lead to avoidance of participation of relevant examinations as CRC-screening. Non-pharmacological anxiety management interventions such as music might contribute to relaxation in the phase prior and during endoscopy. Although music's anxiolytic effects have been reported previously, no objective measurement of stress level reduction has been reported yet. Focus of this study was to evaluate the objective measurement of the state of relaxation in patients undergoing colonoscopy. Methods: Prospective study (n = 196) performed at one endoscopic high-volume center. Standard colonoscopy was performed in control group. Interventional group received additionally self-chosen music over earphones. Facial Electromyography (fEMG) activity was obtained. Clinician Satisfaction with Sedation Instrument (CSSI) and Patients Satisfaction with Sedation Instrument (PSSI) was answered by colonoscopists and patients, respectively. Overall satisfaction with music accompanied colonoscopy was obtained if applicable. Results: Mean difference measured by fEMG via musculus zygomaticus major indicated a significantly lower stress level in the music group [7.700(±5.560) μV vs. 4.820(±3.330) μV; p = 0.001]. Clinician satisfaction was significantly higher with patients listening to music [82.69(±15.04) vs. 87.3(±15.02) pts.; p = 0.001]. Patient's satisfaction was higher but did not differ significantly. Conclusions: We conclude that self-chosen music contributes objectively to a reduced stress level for patients and therefore subjectively perceived satisfaction for endoscopists. Therefore, music should be considered as a non-pharmacological treatment method of distress reduction especially in the beginning of endoscopic procedures.},
  language  = {en}
}
@article{WagnerWannerSchichetal.2017,
  author    = {Wagner, Martin and Wanner, Christoph and Schich, Martin and Kotseva, Kornelia and Wood, David and Hartmann, Katrin and Fette, Georg and R{\"u}cker, Viktoria and Oezkur, Mehmet and St{\"o}rk, Stefan and Heuschmann, Peter U.},
  title     = {Patient's and physician's awareness of kidney disease in coronary heart disease patients - a cross-sectional analysis of the German subset of the EUROASPIRE IV survey},
  series = {BMC Nephrology},
  volume    = {18},
  journal   = {BMC Nephrology},
  number    = {321},
  doi       = {10.1186/s12882-017-0730-3},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-158387},
  year      = {2017},
  abstract  = {Background Chronic kidney disease (CKD) is a common comorbid condition in coronary heart disease (CHD). CKD predisposes the patient to acute kidney injury (AKI) during hospitalization. Data on awareness of kidney dysfunction among CHD patients and their treating physicians are lacking. In the current cross-sectional analysis of the German EUROASPIRE IV sample we aimed to investigate the physician's awareness of kidney disease of patients hospitalized for CHD and also the patient's awareness of CKD in a study visit following hospital discharge. Methods All serum creatinine (SCr) values measured during the hospital stay were used to describe impaired kidney function (eGFR\(_{CKD-EPI}\) < 60 ml/min/1.73m2) at admission, discharge and episodes of AKI (KDIGO definition). Information extracted from hospital discharge letters and correct ICD coding for kidney disease was studied as a surrogate of physician's awareness of kidney disease. All patients were interrogated 0.5 to 3 years after hospital discharge, whether they had ever been told about kidney disease by a physician. Results Of the 536 patients, 32\% had evidence for acute or chronic kidney disease during the index hospital stay. Either condition was mentioned in the discharge letter in 22\%, and 72\% were correctly coded according to ICD-10. At the study visit in the outpatient setting 35\% had impaired kidney function. Of 158 patients with kidney disease, 54 (34\%) were aware of CKD. Determinants of patient's awareness were severity of CKD (OR\(_{eGFR}\) 0.94; 95\%CI 0.92-0.96), obesity (OR 1.97; 1.07-3.64), history of heart failure (OR 1.99; 1.00-3.97), and mentioning of kidney disease in the index event's hospital discharge letter (OR 5.51; 2.35-12.9). Conclusions Although CKD is frequent in CHD, only one third of patients is aware of this condition. Patient's awareness was associated with kidney disease being mentioned in the hospital discharge letter. Future studies should examine how raising physician's awareness for kidney dysfunction may improve patient's awareness of CKD.},
  language  = {en}
}
@article{WagnerSlaghuisGoebeletal.2021,
  author    = {Wagner, Martin and Slaghuis, J{\"o}rg and G{\"o}bel, Werner and V{\´a}zquez-Boland, Jos{\´e} Antonio and Rychli, Kathrin and Schmitz-Esser, Stephan},
  title     = {Virulence pattern analysis of three Listeria monocytogenes lineage I epidemic strains with distinct outbreak histories},
  series = {Microorganisms},
  volume    = {9},
  journal   = {Microorganisms},
  number    = {8},
  issn      = {2076-2607},
  doi       = {10.3390/microorganisms9081745},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-245093},
  year      = {2021},
  abstract  = {Strains of the food-borne pathogen Listeria (L.) monocytogenes have diverse virulence potential. This study focused on the virulence of three outbreak strains: the CC1 strain PF49 (serovar 4b) from a cheese-associated outbreak in Switzerland, the clinical CC2 strain F80594 (serovar 4b), and strain G6006 (CC3, serovar 1/2a), responsible for a large gastroenteritis outbreak in the USA due to chocolate milk. We analysed the genomes and characterized the virulence in vitro and in vivo. Whole-genome sequencing revealed a high conservation of the major virulence genes. Minor deviations of the gene contents were found in the autolysins Ami, Auto, and IspC. Moreover, different ActA variants were present. Strain PF49 and F80594 showed prolonged survival in the liver of infected mice. Invasion and intracellular proliferation were similar for all strains, but the CC1 and CC2 strains showed increased spreading in intestinal epithelial Caco2 cells compared to strain G6006. Overall, this study revealed long-term survival of serovar 4b strains F80594 and PF49 in the liver of mice. Future work will be needed to determine the genes and molecular mechanism behind the long-term survival of L. monocytogenes strains in organs.},
  language  = {en}
}
@article{WagnerKraemerBlohmetal.2014,
  author    = {Wagner, Martin and Kr{\"a}mer, Johannes and Blohm, Elisabeth and Vergho, Dorothee and Weidemann, Frank and Breunig, Frank and Wanner, Christoph},
  title     = {Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry disease},
  doi       = {10.1186/1471-2369-15-188},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-111159},
  year      = {2014},
  abstract  = {Background: Impairments of health related quality of life (HRQoL) are frequently observed in Fabry disease (FD) and are known to be related to neuropathic pain and cardiovascular events. This study aimed to explore the role of chronic kidney disease (CKD) in a large cohort of patients with FD. Methods: In 96 patients (53\% female; age 40 ± 12 yrs) with genetically proven FD, HRQoL was assessed by the Medical Outcomes Study (SF-36) questionnaire. All patients were na{\"i}ve to enzyme replacement therapy. Three categories for kidney dysfunction were chosen, eGFR ≥/<60 ml/min/1.73 m2 or need of renal replacement therapy (RRT). Minor (e.g. arrhythmia, angina pectoris, etc.) and major (e.g. myocardial infarction, coronary artery bypass, stroke or implantable cardioverter-defibrillator) vascular events as well as pain and pain therapy were considered in linear regression analyses with the dimensions of HRQoL. Results: Ten patients (10\%) had impaired kidney function and a further nine were on RRT (9.4\%). Kidney function and pain emerged as the main factors associated with lower scores on the SF 36, in particular on physical components (PCS beta-coefficients for CKD -6.2, for RRT -11.8, for pain -9.1, p < 0.05, respectively), while controlling for gender, vascular event and pain-therapy. Relationships were found for mental aspects of HRQoL. Age and history of vascular events were not related to HRQoL. Conclusion: Cardiovascular events and pain are important factors related to HRQoL, social functioning and depression. Our study highlights impaired chronic kidney disease, in particular after initiation of RRT, as a strong determinant of reduced HRQoL in FD.},
  language  = {en}
}
@article{WagnerAshbyKurtzetal.2015,
  author    = {Wagner, Martin and Ashby, Damien R. and Kurtz, Caroline and Alam, Ahsan and Busbridge, Mark and Raff, Ulrike and Zimmermann, Josef and Heuschmann, Peter U. and Wanner, Christoph and Schramm, Lothar},
  title     = {Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease},
  series = {PLoS One},
  volume    = {10},
  journal   = {PLoS One},
  number    = {4},
  doi       = {10.1371/journal.pone.0123072},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-125514},
  pages     = {e0123072},
  year      = {2015},
  abstract  = {Background Anemia is common and is associated with impaired clinical outcomes in diabetic chronic kidney disease (CKD). It may be explained by reduced erythropoietin (EPO) synthesis, but recent data suggest that EPO-resistance and diminished iron availability due to inflammation contribute significantly. In this cohort study, we evaluated the impact of hepcidin-25—the key hormone of iron-metabolism—on clinical outcomes in diabetic patients with CKD along with endogenous EPO levels. Methods 249 diabetic patients with CKD of any stage, excluding end-stage renal disease (ESRD), were enrolled (2003-2005), if they were not on EPO-stimulating agent and iron therapy. Hepcidin-25 levels were measured by radioimmunoassay. The association of hepcidin-25 at baseline with clinical variables was investigated using linear regression models. All-cause mortality and a composite endpoint of CKD progression (ESRD or doubling of serum creatinine) were analyzed by Cox proportional hazards models. Results Patients (age 67 yrs, 53\% male, GFR 51 ml/min, hemoglobin 131 g/L, EPO 13.5 U/L, hepcidin-25 62.0 ng/ml) were followed for a median time of 4.2 yrs. Forty-nine patients died (19.7\%) and forty (16.1\%) patients reached the composite endpoint. Elevated hepcidin levels were independently associated with higher ferritin-levels, lower EPO-levels and impaired kidney function (all p<0.05). Hepcidin was related to mortality, along with its interaction with EPO, older age, greater proteinuria and elevated CRP (all p<0.05). Hepcidin was also predictive for progression of CKD, aside from baseline GFR, proteinuria, low albumin- and hemoglobin-levels and a history of CVD (all p<0.05). Conclusions We found hepcidin-25 to be associated with EPO and impaired kidney function in diabetic CKD. Elevated hepcidin-25 and EPO-levels were independent predictors of mortality, while hepcidin-25 was also predictive for progression of CKD. Both hepcidin-25 and EPO may represent important prognostic factors of clinical outcome and have the potential to further define "high risk" populations in CKD.},
  language  = {en}
}
@phdthesis{Wagner2019,
  author    = {Wagner, Martin},
  title     = {Untersuchungen zu den kostimulatorischen Signalwegen PD-1/PD-L1 und CD137/CD137L beim kolorektalen Karzinom},
  doi       = {10.25972/OPUS-18434},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-184343},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Kostimulatorische Signalwege spielen beim Zustandekommen einer T-Zell-gebundenen Effektor-Immunantwort eine entscheidende Rolle. In dieser Arbeit wurde die Expression der Signalwege PD-1/PD-L1 und CD137/CD137L im kolorektalen Karzinom untersucht. Hierzu wurde die Expression in den Karzinomen SW480, SW620 und HT-29 mittels qRT-PCR, Western Blot und FACS analysiert. Es konnte gezeigt werden, dass PD-1 und CD137 sowie deren Rezeptoren PD-L1 und CD137L im Kolonkarzinom auf Gen- und Proteinebene exprimiert werden. Zunehmendes Tumorzellwachstum sowie mangelnde N{\"a}hrstoffversorgung f{\"u}hrten zu deutlichen Ver{\"a}nderungen im Expressionsmuster, wobei sich zwischen den Kolonkarzinomen SW480/SW620 und dem Kolonkarzinom HT-29 Unterschiede aufzeigen ließen. Durch die Untersuchungen f{\"u}r diese Arbeit konnten wertvolle Informationen {\"u}ber das Expressionsverhalten der untersuchten kostimulatorischen Signalwege gewonnen werden. Eine m{\"o}gliche Schlussfolgerung ist, dass eine inhibierende PD-1/PD-L1- als auch eine CD137/CD137L-Tumorzell-vermittelte Therapie die Tumorimmunantwort gegen das kolorektale Karzinom st{\"a}rken und damit das {\"U}berleben betroffener Patienten verbessern k{\"o}nnte.},
  subject      = {Kolonkarzinom},
  language  = {de}
}
@phdthesis{Wagner2019,
  author    = {Wagner, Martin},
  title     = {Assoziations- und Haplotypenanalyse genetischer Ver{\"a}nderungen der Pannexin-Gengruppe bei Patienten mit schizophrenen Psychosen nach ICD-10 und der Klassifikation von Karl Leonhard},
  doi       = {10.25972/OPUS-18851},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-188512},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Bestimmung von genetischen Ver{\"a}nderungen auf PANX 1-3 anhand von Einzelnukleotid Polymorphismen (SNP). Test auf Assoziation von Allelen und Haplotypen mit den schizophrenen Psychosen nach ICD-10 und der Klassifikation von Karl Leonhard in Form einer Fall-Kontroll-Studie mit 1163 Patienten und 479 Kontrollen.},
  subject      = {panx1},
  language  = {de}
}
@phdthesis{Wagner2005,
  author    = {Wagner, Martin},
  title     = {Proliferationsverhalten kultivierter Mesangialzellen und glatter Gef{\"a}ßmuskelzellen nach Stimulation mit Angiotensin II und atherogenen Lipoproteinen : Rezeptorbeteiligung},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-15589},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2005},
  abstract  = {Hintergrund: Atherogene Lipoproteine und Angiotensin II sind an der Entstehung von Athe-rosklerose und Glomerulosklerose maßgeblich beteiligt. Sowohl klinische Studien als auch experimentelle Beobachtungen weisen auf eine Interaktion beider Substanzen im Sinne ei-ner Potenzierung ihrer Einzeleffekte hin. Die vorliegende Arbeit untersuchte die Auswirkun-gen von Angiotensin II und nativen und oxidierten Low Density Lipoproteinen (natLDL bzw. oxLDL) auf den Zellzyklus von kultivierten vaskul{\"a}ren Gef{\"a}ßmuskelzellen (BSMC) und Me-sangiumzellen (NHMC) im Sinne einer Proliferations{\"a}nderung unter anderem durch eine Beeinflussung der beteiligten Rezeptoren. Ebenso wurde die Interaktion von oxidierten LDL mit der Zelle sowohl qualitativ als auch quantitativ bestimmt. Methoden: Die Proliferation wurde sowohl mittels radioaktiv markiertem 3H-Thymidin-Einbau als auch durch den MTT-Assay, der auf der photometrisch messbaren Umwandlung von 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl Tetrazoliumbromid beruht, quantifiziert. Die Rezepto-ren wurden auf Proteinebene durch Western Blot Analysen nachgewiesen. Zum Nachweis der Interaktion von oxidierten LDL mit den inkubierten Zellen wurden die oxidierten LDL mit-tels 3,3'-Dioctadecyclindocarbocyanin (DiI) fluoreszenzmarkiert. Visualisiert werden konnte die Interaktion in der Histochemie, die quantitative Bestimmung der DiI-oxLDL-Aufnahme erfolgte durch fluorometische Messung. Ergebnisse: Sowohl native als auch oxidierte LDL steigerten die Proliferation in BSMC und NHMC. In Myozyten lag das Maximum im Tritiumeinbau bei ca. 450\% bezogen auf die Kon-trollzellen bei 10 µg/ml natLDL, und bei ca. 350\% bei 20 µg/ml oxLDL. In NHMC fiel der An-stieg der Proliferation weniger stark aus, ca. 150\% bei 30 µg/ml natLDL und ca. 180\% bei 3 µg/ml oxLDL. Im MTT-Assay konnten signifikante Dosis-Wirkungs-Beziehungen erstellt wer-den, die absolute Proliferationssteigerung war jedoch geringer: BSMC 120\%, NHMC 140\%. Fluoreszenzmarkierte oxLDL wurden {\"u}ber Endozytose in einem konzentrations- und zeitab-h{\"a}ngigen Prozess mit einer S{\"a}ttigung nach ca. 14 Stunden in die Zellen aufgenommen. Der oxLDL-spezifische LOX-1-Rezeptor konnte jederzeit nachgewiesen werden. Durch Angiotensin II alleine und in Co-Inkubation mit atherogenen Lipoproteinen konnte kei-ne Proliferations{\"a}nderung gezeigt werden. Die spezifische Hemmung des AT1-Rezeptors mit Losartan bewirkte ebenfalls keine signifikanten {\"A}nderungen. Auch die Inkubation der Zellen mit Agenzien, die die AT1-Rezeptordichte erh{\"o}hen sollten, erbrachte im Western Blot keine Ver{\"a}nderungen. Im Vergleich unterschiedlich alter Zellpopulationen ließ sich in h{\"o}heren Passagen der proliferationsvermittelnde AT1-Rezeptor kaum nachweisen, jedoch war in die-sen Zellpopulationen der antagonistisch wirkende AT2-Rezeptor stark exprimiert. Zusammenfassung: Atherogene Lipoproteine beeinflussen zeit- und konzentrationsabh{\"a}ngig m{\"o}glicherweise {\"u}ber eine LOX-1 vermittelte Endozytose den Zellzyklus von kultivierten glat-ten Muskelzellen und Mesangiumzellen im Sinne einer Proliferationssteigerung. Die uneinheitlichen Effekte von Angiotensin II auf die Proliferationsrate k{\"o}nnen durch die starken Expressionsschwankungen der antagonistisch wirkenden Angiotensin II-Rezeptor-Subtypen (AT1 und AT2) vor allem in unterschiedlich alten Zellpopulationen erkl{\"a}rt werden. Wodurch diese Expressionsver{\"a}nderungen verursacht sind, ist gegenw{\"a}rtig noch unklar, ebenso, ob diese Effekte im atherosklerotischen Plaque in vivo nachweisbar und pathophy-siologisch bedeutsam.},
  language  = {de}
}
@phdthesis{Wagner2022,
  author    = {Wagner, Martin},
  title     = {Zyto- und Gentoxizit{\"a}t von Zinkoxid-Nanopartikeln in humanen mesenchymalen Stammzellen nach repetitiver Exposition und im Langzeitversuch},
  doi       = {10.25972/OPUS-27572},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-275726},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2022},
  abstract  = {Zinkoxid-Nanopartikel (ZnO-NP) finden in vielen Produkten des t{\"a}glichen Verbrauchs Verwendung. Daten {\"u}ber die toxikologischen Eigenschaften von ZnO-NP werden kontrovers diskutiert. Die menschliche Haut ist in Bezug auf die ZnO-NP Exposition das wichtigste Kontakt-Organ. Intakte Haut stellt eine suffiziente Barriere gegen{\"u}ber NP dar. Bei defekter Haut ist ein Kontakt zu den proliferierenden Stammzellen m{\"o}glich, sodass diese als wichtiges toxikologische Ziel f{\"u}r NP darstellen. Das Ziel dieser Dissertation war die Bewertung der genotoxischen und zytotoxischen Effekte an humanen mesenchymalen Stammzellen (hMSC) durch niedrig dosierte ZnO-NP nach 24 st{\"u}ndiger Exposition, repetitiven Expositionen und im Langzeitversuch bis zu 6 Wochen. Zytotoxische Wirkungen von ZnO-NP wurden mit 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromid-Test (MTT) gemessen. Dar{\"u}ber hinaus wurde die Genotoxizit{\"a}t durch den Comet-Assay bewertet. Zur Langzeitbeobachtung bis zu 6 Wochen wurde die Transmissionselektronenmikroskopie (TEM) verwendet. Zytotoxizit{\"a}t nach 24-st{\"u}ndiger ZnO-NP-Exposition war ab einer Konzentration von 50 µg/ml nachweisbar. Genotoxizit{\"a}t konnten bereits bei Konzentrationen von 1 und 10 µg/ml ZnO-NP beschrieben werden. Wiederholte Exposition verst{\"a}rkte die Zyto-, aber nicht die Genotoxizit{\"a}t. Eine intrazellul{\"a}re NP-Akkumulation mit Penetration der Zellorganelle wurde bei einer Exposition bis zu 6 Wochen beobachtet. Die Ergebnisse deuten auf zytotoxische und genotoxisches Effekte von ZnO-NP hin. Bereits geringe Dosen von ZnO-NP k{\"o}nnen bei wiederholter Exposition toxische Wirkungen hervorrufen sowie eine langfristige Zellakkumulation. Diese Daten sollten bei der Verwendung von ZnO-NP an gesch{\"a}digter Haut ber{\"u}cksichtigt werden.},
  subject      = {nanoparticle},
  language  = {de}
}